Skip to main content
Chase Science Co.,Ltd logo

Chase Science Co.,Ltd — Investor Relations & Filings

Ticker · 300941 ISIN · CNE100004CZ0 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 514 across all filing types
Latest filing 2022-05-05 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300941

About Chase Science Co.,Ltd

https://www.echase.cn

Chase Science Co., Ltd. specializes in the research, development, manufacturing, and distribution of medical puncture instruments and laboratory consumables. The company's core product portfolio includes a wide range of medical devices such as safety syringes, insulin syringes, hypodermic needles, and infusion sets designed for clinical use. Additionally, the firm produces specialized veterinary medical instruments and laboratory plasticware. Chase Science emphasizes the integration of safety-engineered technologies into its products to minimize needle-stick injuries and enhance patient care. With a focus on high-precision manufacturing and international quality standards, the company serves a global market, providing essential medical supplies to healthcare facilities and research institutions. Its operations are characterized by a commitment to technological innovation in the field of medical consumables and puncture technology.

Recent filings

Filing Released Lang Actions
关于使用部分暂时闲置募集资金进行现金管理进展的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the progress of using temporarily idle raised funds for cash management. It details the investment products, approval procedures, risk control measures, and the impact on daily operations. It does not contain financial statements or comprehensive financial data but rather updates on financing activities related to the use of raised funds. The document length is 3377 characters, which is relatively short and focused on a specific financing update. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2022-05-05 Chinese
2021年度独立董事述职报告（杨小明）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report for 2021" from Fujian Chuangshi Technology Co., Ltd. It details the independent director's attendance at board meetings, opinions on various board resolutions, supervision of company governance and information disclosure, and other duties performed during the year 2021. The content is a narrative report on the independent director's activities and opinions rather than a financial report or announcement. It does not contain financial statements, earnings data, or regulatory filings. It is a management-related report focusing on governance and oversight by an independent director. Therefore, the document fits best under the category of Board/Management Information (MANG), which includes announcements or reports related to board members and their activities.
2022-04-24 Chinese
2021年年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2021 年度内部控制自我评价报告' which translates to '2021 Annual Internal Control Self-Evaluation Report' for Fujian Chuangshi Technology Co., Ltd. It is a detailed report on the company's internal control system, its effectiveness, and compliance with relevant laws and regulations. The document includes extensive discussion on internal control environment, risk assessment, control activities, information and communication, and supervision. It also covers internal control defect identification and remediation, and plans for improvement. The document is lengthy (over 11,000 characters) and contains substantive content related to internal control evaluation rather than just an announcement or certification. This type of report is typically considered an Audit Report / Information (AR) as it focuses on internal control evaluation and compliance, which is distinct from a full Annual Report (10-K) or Interim Report (IR). It is not a certification letter or a brief announcement, so it does not fall under Regulatory Filings (RNS) or Report Publication Announcement (RPA). Therefore, the most appropriate classification is AR (Audit Report / Information).
2022-04-24 Chinese
2021年度独立董事述职报告（刘泽军）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report for 2021" from Fujian Chuangshi Technology Co., Ltd. It details the independent director's attendance at board meetings, opinions on various board resolutions, supervision of company governance, and protection of minority shareholders' rights during the 2021 fiscal year. The content is a narrative report on the independent director's duties and activities rather than a financial report or announcement. It does not contain financial statements or earnings data, nor is it an announcement of voting results or management changes. This type of document fits best under the category of Board/Management Information (MANG), as it relates to board activities and governance oversight by an independent director.
2022-04-24 Chinese
关于召开2021年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2021 Annual General Meeting (AGM) of Fujian Chuangshi Technology Co., Ltd. It includes information about the meeting date, voting procedures, proposals to be discussed, registration details, and attachments such as proxy forms and voting instructions. The document does not contain the actual annual report or financial statements but rather the announcement and logistical details for the AGM. Therefore, it fits the category of AGM Information (AGM-R). The document length is over 5,000 characters and contains substantive meeting details, confirming it is not merely a brief announcement or regulatory filing.
2022-04-24 Chinese
关于公司续聘会计师事务所公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the reappointment of the audit firm for the fiscal year 2022. It details the qualifications, independence, and integrity of the audit firm, the audit fees, and the approval process by the board and independent directors. It does not contain actual financial statements or audit results but rather informs shareholders and the public about the decision to continue with the audit firm and the related procedures. The document length is under 5,000 characters and serves as a formal announcement rather than the audit report itself. Therefore, it fits best under the category of Audit Report / Information (AR), as it relates specifically to audit firm appointment and audit-related disclosures, but is not a full annual report or financial statement.
2022-04-24 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.